| Gene Symbol | ADRA2A |
| Target Class | Gpcr |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Mechanism of Action | Small molecule agonists and antagonists modulating noradrenergic signaling |
| Druggability | Medium (0.59) |
| Clinical Stage | Approved |
| GeneCards | ADRA2A |
| Human Protein Atlas | ADRA2A |
| Drug | Use |
| Clonidine | Hypertension, ADHD |
| Guanfacine | Hypertension, ADHD |
| Dexmedetomidine | Sedation |
| Brimonidine | Glaucoma |
| Yohimbine | Reversal of α2 blockade |
| Atipamezole | Veterinary reversal |
| Associated Diseases | neurodegeneration |
| Known Drugs/Compounds | Dexmedetomidine, Clonidine |
| SciDEX Target | View Target Profile (8 clinical trials) |
| SciDEX Hypotheses | Noradrenergic-Tau Propagation Blockade |
| KG Connections | 3 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |